EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage

Loren Kell iD, Eleanor J Jones iD, Nima Gharahdaghi iD, Daniel J Wilkinson iD, Kenneth Smith iD, Philip J Atherton iD, Anna K Simon iD, Lynne S Cox iD, Ghada Alsaleh iD

Aging Cell · 2026-02 · 25 (2)

DOI: 10.1111/acel.70364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 12.01.2026. Verfasst von Loren Kell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Sirolimus, DNA Damage, Aging, Immune System. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz Association, Mellon Longevity Graduate Programme at Oriel College, University of Oxford, Versus Arthritis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mTOR inhibitors such as rapamycin are among the most robust life‐extending interventions known, yet the mechanisms underlying their geroprotective effects in humans remain incompletely understood. At non‐immunosuppressive doses, these drugs are senomorphic, that is, they mitigate cellular senescence, but whether they protect genome stability itself has been unclear. Given that DNA damage is a major driver of immune ageing, and immune decline accelerates whole‐organism ageing, we tested whether mTOR inhibition enhances genome stability. In human T cells exposed to acute genotoxic stress, we found that rapamycin and other mTOR inhibitors suppressed senescence not by slowing protein synthesis, halting cell division, or stimulating autophagy, but by directly reducing DNA lesional burden and improving cell survival. Ex vivo analysis of aged immune cells from healthy donors revealed a stark enrichment of markers for DNA damage, senescence, and mTORC hyperactivation, suggesting that human immune ageing may be amenable to intervention by low‐dose mTOR inhibition. To test this in vivo, we conducted a placebo‐controlled experimental medicine study in older adults administered with low‐dose rapamycin. p21, a marker of DNA damage‐induced senescence, was significantly reduced in immune cells from the rapamycin compared to placebo group. These findings reveal a previously unrecognised role for mTOR inhibition: direct genoprotection. This mechanism may help explain rapamycin's exceptional geroprotective profile and opens new avenues for its use in contexts where genome instability drives pathology, ranging from healthy ageing, clinical radiation exposure and even the hazards of cosmic radiation in space travel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirolimusDNA DamageAgingImmune SystemHumansMaleCellular SenescenceFemaleAgedTOR Serine-Threonine KinasesT-LymphocytesT-Cell Senescence

Stichwörter der Autor:innen

DNA damageageingcell senescencegenome stabilityimmunosenescencemTORrapamycin

Substanzen

SirolimusTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Biochemistry, University of Oxford, Oxford, UK.
  • Botnar Institute for Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
  • The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
  • MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Centre of Metabolism, Ageing and Physiology (COMAP), Academic Unit of Injury, Recovery and Inflammation Sciences (IRIS), School of Medicine, University of…
  • School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
  • Centre for Human Genetics (CHG), University of Oxford, Oxford, UK.

ORCID-Profile: Loren Kell, Eleanor J Jones, Nima Gharahdaghi, Daniel J Wilkinson, Kenneth Smith, Philip J Atherton, Anna K Simon, Lynne S Cox, Ghada Alsaleh

Förderung

  • Helmholtz Association
  • Mellon Longevity Graduate Programme at Oriel College, University of Oxford
  • Versus Arthritis
  • Biotechnology and Biological Sciences Research Council
  • Diabetes UK/BIRAX
  • Public Health England
  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Kell, L., Jones, E. J., Gharahdaghi, N., Wilkinson, D. J., Smith, K., Atherton, P. J., Simon, A. K., Cox, L. S., & Alsaleh, G. (2026). Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage. Aging Cell, 25(2). https://doi.org/10.1111/acel.70364

Vancouver

Kell L, Jones EJ, Gharahdaghi N, Wilkinson DJ, Smith K, Atherton PJ, et al. Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage. Aging Cell. 2026;25(2). doi:10.1111/acel.70364

BibTeX
@article{Kell2026,
  author = {Kell, Loren and Jones, Eleanor J and Gharahdaghi, Nima and Wilkinson, Daniel J and Smith, Kenneth and Atherton, Philip J and Simon, Anna K and Cox, Lynne S and Alsaleh, Ghada},
  title = {Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {2},
  doi = {10.1111/acel.70364}
}
Kostenlos starten →